Invivoscribe® is a global technology-driven company focused on precision diagnostics with best-in-class products and services that detect hematologic malignancies to optimize patient care and accelerate drug approvals. Our international LabPMM® network (US, Europe, Asia) offers standardized flow cytometry and molecular testing that support therapeutic decisions, MRD monitoring, and CDx development.